KalVista Submits New Drug Application to FDA for Sebetralstat as First Oral On-demand Treatment for Hereditary Angioedema

View Full Size 

Download

• Full Size JPEG, 2580x2550, 541.9 KB
• Small JPEG, 480x474, 104.4 KB
• Preview JPEG, 144x142, 46.8 KB
• Thumbnail JPEG, 71x70, 34.8 KB